1. Lipopolysaccharide-Induced Inflammatory Response and Its Prominent Suppression by Paspalum thunbergii Extract.
- Author
-
Ha B, Kang JH, Kim DH, and Lee MY
- Subjects
- Mice, Animals, RAW 264.7 Cells, Inflammation drug therapy, Inflammation metabolism, Inflammation chemically induced, NF-kappa B metabolism, Macrophages drug effects, Macrophages metabolism, Antioxidants pharmacology, Signal Transduction drug effects, Nitric Oxide Synthase Type II metabolism, Wnt Signaling Pathway drug effects, Lipopolysaccharides, Plant Extracts pharmacology, Plant Extracts chemistry, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents chemistry, Nitric Oxide metabolism
- Abstract
The extract of Paspalum thunbergii , a native perennial herb in Korea belonging to the rice family, was investigated for its anti-inflammatory activity and the underlying mechanisms driving its effects. Fifteen chemical components of the P. thunbergii extract, including rosmarinic acid and isoquercitrin, were identified using LC-MS. The extract showed antioxidative activity through DPPH and ABTS cation radical scavenging activity. The P. thunbergii extract significantly inhibited lipopolysaccharide (LPS)-induced nitric oxide (NO) production in macrophage RAW 264.7 cells. The extract inhibited the expression of lipopolysaccharide-induced iNOS and COX-2, which are inflammation-related enzymes. To explore the underlying anti-inflammatory mechanism, the expression levels of signal proteins related to MAPK, NF-κB, JAK/STAT, and Wnt/β-catenin signaling were measured. As a result, the P. thunbergii extract inhibited the expression of p-p38, and p-JNK increased by LPS in RAW 264.7 cells. Additionally, it decreased the expression of LPS-induced p-IKKβ and p-NF-κB p65 and prevented the migration of p-NF-κB into the nucleus caused by LPS. Notably, p-JAK1, p-STAT3, Wnt 3α, β-catenin, and p-GSK-3β protein expressions were also inhibited. Therefore, the prominent anti-inflammatory activity of the P. thunbergii extract may be via the MAPK, NF-κB, JAK/STAT, Wnt/β-catenin signal pathway., Competing Interests: Author Do Hyun Kim was employed by the company Eshel Biopharm Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2025
- Full Text
- View/download PDF